IPS HEART
- Biotech or pharma, therapeutic R&D
IPS Heart is a privately held cell therapy company founded in 2014 and is advancing its stem cell platform for generation of new skeletal muscle and new cardiac muscle to treat Duchenne Muscular Dystrophy and heart failure.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}